Patents by Inventor ROMAIN FERRU-CLEMENT

ROMAIN FERRU-CLEMENT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METABOLIC BIOMARKERS OF INFLAMMATORY BOWEL DISEASE
    Publication number: 20230349933
    Abstract: Disclosed are various lipid biomarkers of inflammatory bowel disease, including biomarkers for inflammatory bowel diseases including Crohn’s disease and Ulcerative colitis. Also disclosed are various biomarkers of disease location and/or disease behavior in inflammatory bowel disease. The present disclosure also provides methods of using the biomarkers, including methods for diagnosis of inflammatory bowel disease, methods of determining predisposition to inflammatory bowel disease, methods of monitoring progression/regression of inflammatory bowel disease, and methods of assessing efficacy of compositions for treating inflammatory bowel disease.
    Type: Application
    Filed: April 27, 2023
    Publication date: November 2, 2023
    Inventors: John D. RIOUX, Christine DES ROSIERS, Anik FOREST, Gabrielle BOUCHER, Romain FERRU-CLÉMENT
  • Compounds, compositions and corresponding uses for preventing and/or treating of dyslipidemia
    Patent number: 9821000
    Abstract: The present invention relates to the field of medicine. It relates more particularly to the use of compounds to prevent and/or treat lipotoxicity in a subject, especially lipotoxicity by hypoxia. The invention relates more particularly to compositions, especially pharmaceuticals compositions and nutritional supplements or complements comprising such compounds as well as their use to prevent and/or treat lipotoxicity, especially lipotoxicity by hypoxia. The compounds and compositions of the invention can especially be advantageously used to prevent and/or treat a pathology from among pulmonary pathologies, especially cystic fibrosis or a chronic obstructive pulmonary disease.
    Type: Grant
    Filed: October 8, 2014
    Date of Patent: November 21, 2017
    Assignee: Centre National de la Recherche Scientifique (CNRS)
    Inventors: Thierry Ferreira, Romain Ferru-Clement, Clarisse Vandebrouck
  • COMPOUNDS, COMPOSITIONS AND CORRESPONDING USES FOR PREVENTING AND/OR TREATING OF DYSLIPIDEMIA
    Publication number: 20160287542
    Abstract: The present invention relates to the field of medicine. It relates more particularly to the use of compounds to prevent and/or treat lipotoxicity in a subject, especially lipotoxicity by hypoxia. The invention relates more particularly to compositions, especially pharmaceuticals compositions and nutritional supplements or complements comprising such compounds as well as their use to prevent and/or treat lipotoxicity, especially lipotoxicity by hypoxia. The compounds and compositions of the invention can especially be advantageously used to prevent and/or treat a pathology from among pulmonary pathologies, especially cystic fibrosis or a chronic obstructive pulmonary disease.
    Type: Application
    Filed: October 8, 2014
    Publication date: October 6, 2016
    Inventors: THIERRY FERREIRA, ROMAIN FERRU-CLEMENT, CLARISSE VANDEBROUCK